Latest It Services News

Connexion Mobility reports robust Q2 FY25 results with revenue and net profit surging, driven by subscription growth and strategic product launches. The company’s focus on user engagement and marketplace expansion signals promising long-term shareholder value.

VIP Gloves Limited reports a sharp decline in quarterly sales receipts as it invests heavily in restarting manufacturing operations, while legal proceedings continue to loom.

Spacetalk Limited reports a robust 12% increase in Annual Recurring Revenue to $11 million, driven by a 21% jump in paid mobile subscribers, signaling strong momentum and international ambitions.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 NRI stores nationwide. This partnership aims to boost RLF’s Australian market presence and support sustainable farming practices.

Genesis Minerals Limited reported a record December quarter gold production of 57,055oz, driven by an accelerated Laverton mill restart and strong operational execution. The company’s cash reserves surged 34% to A$238 million, underpinning its debt-free growth strategy.

MLG Oz Limited has locked in contracts worth over $45 million annually with Northern Star Resources, extending a partnership spanning more than 10 years across key Western Australian gold operations.

Latitude Group Holdings Limited has revised its distribution on Capital Notes from AUD 1.6136 to AUD 2.3052, reflecting a shift to a 0% franked component and the introduction of conduit foreign income.

Horizon Minerals has poured its first gold bar from the Boorara Gold Project, initiating production under a key ore sale agreement and setting the stage for a sustainable gold pipeline.

AUCyber Limited reveals a challenging half-year with a $1.6 million EBITDA loss on $12.2 million revenue, alongside operational setbacks and a rejected takeover bid from 5GN Networks.

Cardno Limited has requested an immediate suspension from ASX quotation to facilitate its removal from the official ASX list, marking a significant step in its delisting process.

Immuron has submitted its Phase 2 clinical study report for Travelan® to the FDA, revealing statistically significant immunological and microbiome benefits. The company is preparing to engage the FDA for Phase 3 trial discussions while progressing a large field study with military personnel.

Vonex Limited has vested performance rights for its CEO and directors following MaxoTel’s acquisition of majority control, with shares set to be sold on-market. The company reports a mixed 1H FY25 financial performance and is exploring options to repay a $23 million debt facility, including a potential capital raise.